AC BioScience SA

AC BioScience is a start-up biotech company with an innovative vision and business model. We are dedicated to developing new therapies to fight a range of cancers.

Founded by Andreas Schläpfer and Professor Christian Auclair, the company is leading a paradigm shift in cancer therapeutics. AC BioScience is headquartered at the EPFL Innovation Park near Lausanne, and celebrated its second year of existence in March 2019.

Our primary focus is on developing personalized therapies for tumoral pathologies. We have obtained patent protection for one ground-breaking cancer therapy and have filed patents for two others.